This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
And they used NetBase Quid to inform their research. We’ll provide a high-level summary here, and some practical applications of frameworks they’ve used that could apply to powering your own research on any number of topics. Investment intelligence to inform deep tech understanding. From here, the biotech world is your oyster.
Attracting industry leaders, emerging fast-growth companies, and technology creators from around the world, life science corporations share their latest advances, leading research, and best practices — as well as their intentions to scale their digital health solutions — to the masses in hopes of securing capital.
Moderna and BioTech, the pharmaceuticals companies behind the Moderna vaccines for the COVID-19 virus, just announced a new treatment this past December that would greatly reduce the chances of death from melanoma — stirring up substantial interest in investors to funnel capital. a potential cure for skin cancer.
Research shows that the AI in asset management market will grow at a staggering 34% CAGR through 2027. The time is now to invest in a marketintelligence platform with AI search capabilities, so you can speed up your research and outperform the market. Artificial intelligence is the only way to do it.
Below, we explore the factors constraining venture capital funding into the first half of the year, and the ways investors can leverage crucial marketintelligence to gain a competitive advantage in the shifting landscape. Want to learn about how AlphaSense is empowering venture capital firms to accelerate their research efforts?
This approach enables providers to gather data about the molecular mechanisms of an individual being tested, which further enables researchers to develop targeted therapies and preventive strategies. The precision therapeutics is segmented into clinical trials, cell therapy, drug discovery and research, and gene therapy.
The Transformative Effect of Generative AI By 2025, it is estimated that more than 75% of venture capital (VC) and early-stage investor executive reviews will be informed using artificial intelligence (AI) and data analytics. There is no doubt that generative AI has emerged as a powerful tool in the investment space.
By leveraging our proprietary approach to research and insight development, our skilled team of competitive strategy professionals follows a systematic “Four I’s” process to gather Information, analyze Intelligence, uncover Insights, and contextualize Implications. Assess and benchmark enrollment timing.
The 10 initial drugs were chosen based on certain criteria set out by Medicare: they must be sold in pharmacies, not have substantial generic competition , and have been on the market for at least nine to 13 years for more complex biotech drugs. That’s why more professionals are turning to marketintelligence solutions like AlphaSense.
Attracting industry leaders, emerging fast-growth companies, and technology creators from around the world, life science corporations share their latest advances, leading research, and best practices—as well as their intentions to scale their digital health solutions—to the masses in hopes of securing capital.
2023 was all about learning the use cases of genAI, as companies raced to introduce their own genAI offerings and capabilities into a fiercely competitive market (i.e. In fact, projections for the global spatial computing market are valued at $269.8 billion by 2030 with a CAGR of 23.1%
AlphaSense, a leading artificial intelligence (AI)-based marketintelligence platform , offers proprietary Expert Insights through its extensive expert transcript library and Expert Call Services. Similarly, expert calls fill particular roles.
We expand on these features in greater detail below: Semantic Search With our AI search technology, you no longer have to manually CTRL-F through fragmented research documents and reports. This means you can shave hours of time off your research and be more confident in the accuracy and comprehensiveness of your results.
The ability to bring drugs and therapies to market sooner, with less intrinsic cost, ultimately leads to stronger valuations and greater stakeholder value. Our 10,000+ high-quality content sources from more than 1,500 leading research providers put you at the forefront of marketintelligence—all within a single platform.
These first-hand perspectives are a critical addition to the secondary research that most professionals rely on in their marketresearch, landscaping, and monitoring. Which company provides access to the most in-depth, varied expertise that will ultimately eliminate blind spots in your research?
Boston’s innovation business ecosystem—from biotech startups in Kendall Square to fintech firms downtown—relies heavily on quality consumer insights. But with so many options for marketresearch, from traditional focus group facilities to modern research platforms, finding the right partner isn’t always straightforward.
Founded in 2007, Civic Science is a consumer intelligenceresearch platform that polls millions of Americans each week covering thousands of topics. Their proprietary InsightStore analyzes the responses so decision-makers can discover the market and cultural trends. You’re listening to the Happy MarketResearch podcast.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content